Information Collection
Small Group Discussions with Applicants and Other External Stakeholders Regarding Clarity, Understandability, and Usefulness of FDA's Benefit-Risk Framework (BRF)
IC 251530 under ICR 202206-0910-016 · OMB 0910-0697.
⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0697 can be found here: